At present, the four main innovative methods for treating NAFLD include the use of anti‐oxidative stress drugs and the use of drugs targeting the FXR axis, namely obeticholic acid. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.